Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xu‐Ya Zhao"'
Autor:
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu, Gao-Jun Teng, for the CHANCE001 Investigators
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC). It is necessary to investigat
Externí odkaz:
https://doaj.org/article/0be907c2391b401e85670015bfb6cca0
Autor:
Shuai Zhang, Zhi‐Mei Cheng, Jia‐LI Yu, Kai Lu, Sheng‐Jie Xu, Yuan Lu, Ting Liu, Bai‐Juan Xia, Zhi Huang, Xu‐Ya Zhao, Wei He, Jun‐Xiang Li, Wei Cao, Yu Huang, Ling Wang, Zhu Zeng, Xun Zou, Rong Liu, Yu‐Sui Zhang, Xiao‐Ping Wu, Tian‐Peng Jiang, Shi Zhou
Publikováno v:
Cancer Medicine, Vol 10, Iss 19, Pp 6795-6806 (2021)
Abstract The incidence and mortality of hepatocellular carcinoma (HCC) are gradually increasing during the past years. Recently, some studies have reported that malic enzyme (ME) plays an important role in cancer development, while the involvement of
Externí odkaz:
https://doaj.org/article/638a5e3032414ee1847aeaf1dd3c4c62
Autor:
Shuai Zhang, Yuan Lu, Hong-Yu Jiang, Zhi-Mei Cheng, Zi-Jing Wei, Yun-Hao Wei, Ting Liu, Bai-Juan Xia, Xu-Ya Zhao, Yu Huang, Xun Zou, Rong Liu, Shi Zhou
Publikováno v:
Cell Death and Disease, Vol 12, Iss 6, Pp 1-13 (2021)
Abstract Circular RNA (circRNAs) functions vital in the pathogenesis and progression of hepatocellular carcinoma (HCC). However, the expressions and functions of certain circRNAs on metastasis and proliferation of that cancer is still unclear. Bioinf
Externí odkaz:
https://doaj.org/article/efbeaa8bd27943a384c9b53b7f8343bb
Autor:
Hai-Dong Zhu, Xiao Li, Jian-Song Ji, Ming Huang, Guo-Liang Shao, Jian Lu, Xu-Ya Zhao, Hai-Liang Li, Zheng-Qiang Yang, Jian-Fei Tu, Jin-Mei Zhou, Chu-Hui Zeng, Gao-Jun Teng
Publikováno v:
European radiologyReferences. 32(11)
To investigate the efficacy and safety of dicycloplatin as chemotherapeutic regimen in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).In this randomized, open-label, phase II trial, patients with unresectable HCC w
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-9 (2019)
Cancer Cell International
Cancer Cell International
Background Glioma is a lethal malignant brain tumor, which affects the brain functions and is life-threatening. LncRNA UCA1 was identified as a pivotal regulator for tumorigenesis of glioma. MiR-206 was discovered to promote tumorigenesis and is crit